within Pharmacolibrary.Drugs.ATC.A;

model A16AX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00115,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A16AX05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Zinc acetate is an inorganic salt used as a zinc supplement, primarily to treat Wilson's disease, a rare genetic disorder that causes copper accumulation in tissues. It is also sometimes used for zinc deficiency and in lozenges for the symptomatic relief of common cold. It is an approved drug and currently used in clinical practice, especially for Wilson’s disease.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals, as no direct human PK model studies are available in the literature for zinc acetate specifically.</p><h4>References</h4><ol><li><p>Henderson, LM, et al., &amp; Berardi, RR (1995). Effect of intragastric pH on the absorption of oral zinc acetate and zinc oxide in young healthy volunteers. <i>JPEN. Journal of parenteral and enteral nutrition</i> 19(5) 393–397. DOI:<a href=&quot;https://doi.org/10.1177/0148607195019005393&quot;>10.1177/0148607195019005393</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8577018/&quot;>https://pubmed.ncbi.nlm.nih.gov/8577018</a></p></li><li><p>Brewer, GJ, et al., &amp; Padgett, G (1992). Use of zinc acetate to treat copper toxicosis in dogs. <i>Journal of the American Veterinary Medical Association</i> 201(4) 564–568. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1517130/&quot;>https://pubmed.ncbi.nlm.nih.gov/1517130</a></p></li><li><p>Eby, GA (2010). Zinc lozenges as cure for the common cold--a review and hypothesis. <i>Medical hypotheses</i> 74(3) 482–492. DOI:<a href=&quot;https://doi.org/10.1016/j.mehy.2009.10.017&quot;>10.1016/j.mehy.2009.10.017</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19906491/&quot;>https://pubmed.ncbi.nlm.nih.gov/19906491</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A16AX05;
